Novo Nordisk sues Eli Lilly over weight-loss ads citing outdated trial data
The lawsuit alleges Lilly's Zepbound and Mounjaro marketing leans on stale evidence to exaggerate efficacy versus rivals.
By Mohammed Al-Shehri·· 3 min
Loading the Newsroom
Curating from trusted global sources…